表紙
市場調查報告書

日本的糖尿病市場:患者數、盛行率、口服抗糖尿病藥物、胰島素、診斷

Japan Diabetes Market Report: 2019-2024

出版商 IMARC Services Private Limited 商品編碼 345919
出版日期 內容資訊 英文 89 Pages
商品交期: 2-3個工作天內
價格
Back to Top
日本的糖尿病市場:患者數、盛行率、口服抗糖尿病藥物、胰島素、診斷 Japan Diabetes Market Report: 2019-2024
出版日期: 2019年04月08日內容資訊: 英文 89 Pages
簡介

本報告提供日本的糖尿病市場相關調查分析,現在、未來趨勢 (盛行率、人口統計、診斷、治療) 相關驗證,流行病學,市場趨勢,治療結構,競爭結構,市場預測等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 糖尿病概要

  • 所謂糖尿病
  • 糖尿病的診斷和治療
  • 糖尿病的併發症

第4章 促進日本的糖尿病市場的主要原因

第5章 日本的糖尿病的流行病學

  • 糖尿病人口和盛行率
  • 人口和盛行率:各糖尿病類型 (一型、2型)
  • 人口和盛行率:各地區
  • 人口和盛行率:性別
  • 人口和盛行率:各年齡層
  • 糖尿病的診斷與藥物治療率

第6章 日本的糖尿病市場

  • 過去的市場趨勢
  • 市場預測
  • 市場明細:各市場區隔
  • 日本的口服抗糖尿病藥物市場
  • 日本的胰島素市場

第7章 日本的糖尿病診斷市場

  • 過去的市場趨勢
  • 市場區隔
  • 主要企業

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SR1018G53_Report

The Japan diabetes market reached a value of more than US$ 4 Billion in 2018, registering a CAGR of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR of 3.8% during 2019-2024. Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes.

Japan Diabetes Market Drivers:

  • With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.

Breakup by Segment:

  • Oral Antidiabetics
  • Insulin
  • Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.

Competitive Landscape

  • the Competitive Landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.

Key Questions Answered in This Report:

  • How has the Japan diabetes market performed so far and how will it perform in the coming years?
  • Which are the popular segments in the Japan diabetes market?
  • What are the various stages in the value chain of the Japan diabetes market?
  • What are the key driving factors and challenges in the Japan diabetes market?
  • What is the structure of the Japan diabetes market and who are the key players?
  • What is the degree of competition in the Japan diabetes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Diabetes Disease Overview

  • 5.1 What is Diabetes?
  • 5.2 Diabetes Diagnosis and Treatment
    • 5.2.1 Diagnosis
    • 5.2.2 Treatment
  • 5.3 Diabetes Complications

6 Japan Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group

7 Japan Diabetes Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Forecast
  • 7.4 SWOT Analysis
    • 7.4.1 Overview
    • 7.4.2 Strengths
    • 7.4.3 Weaknesses
    • 7.4.4 Opportunities
    • 7.4.5 Threats
  • 7.5 Value Chain Analysis
  • 7.6 Porter's Five Forces Analysis
    • 7.6.1 Overview
    • 7.6.2 Bargaining Power of Buyers
    • 7.6.3 Bargaining Power of Suppliers
    • 7.6.4 Degree of Competition
    • 7.6.5 Threat of New Entrants
    • 7.6.6 Threat of Substitutes
  • 7.7 Market Breakup by Segment
    • 7.7.1 Japan Oral Antidiabetics Market
      • 7.7.1.1 Historical Market Trends
      • 7.7.1.2 Market Breakup by Class
      • 7.7.1.3 Market Shares of Key Players
      • 7.7.1.4 Market Forecast
    • 7.7.2 Japan Insulin Market
      • 7.7.2.1 Historical Market Trends
      • 7.7.2.2 Market Breakup by Class
      • 7.7.2.3 Market Shares of Key Players
      • 7.7.2.4 Market Forecast

8 Competitive Landscape

  • 8.1 Competitive Structure
  • 8.2 Profiles of Key Players

List of Figures

  • Figure 1: The Impact of Diabetes in the Human Body
  • Figure 2: Diabetes Complications
  • Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
  • Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 5: Japan: Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 6: Japan: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
  • Figure 7: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 8: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2019-2024
  • Figure 9: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 10: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2019-2024
  • Figure 11: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 12: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2019-2024
  • Figure 13: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2011-2018
  • Figure 14: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2019-2024
  • Figure 15: Japan: Diabetes Drug Industry Overview
  • Figure 16: Japan: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
  • Figure 17: Japan: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Japan: Diabetes Drug Market: SWOT Analysis
  • Figure 19: Japan: Diabetes Drug Market: Value Chain Analysis
  • Figure 20: Japan: Diabetes Drug Market: Porters Five Forces Analysis
  • Figure 21: Japan: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
  • Figure 22: Japan: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
  • Figure 23: Japan: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
  • Figure 24: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
  • Figure 25: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 26: Japan: Oral Antidiabetics Market Forecast: Sales Value (in Million US$) 2019-2024
  • Figure 27: Japan: Insulin Market: Sales Value (in Million US$), 2011-2018
  • Figure 28: Japan: Breakup of Insulin Market by Class (in %), 2018
  • Figure 29: Japan: Insulin Market: Sales Share of Key Players (in %)
  • Figure 30: Japan: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Diagnosis of Diabetes
  • Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2018 and 2024
  • Table 3: Japan: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 4: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 5: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 6: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 7: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2011, 2018 & 2024
  • Table 8: Japan: Diabetes Drug Market: Competitive Structure
Back to Top